Alpha Tau Medical Ltd (DRTS) vs Eton Pharmaceuticals, Inc. (ETON)

A side-by-side comparison of Alpha Tau Medical Ltd and Eton Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DRTS vs ETON

growth of $100 · dividends reinvested · last 6y
DRTS +47.4% (+6.7%/yr)ETON +643.6% (+39.7%/yr)ETON compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020222023202420252026$147$744
DRTS ETON

DRTS vs ETON: by the numbers

  • •ETON is the larger company ($1.52B vs $1.34B market cap).
  • •ETON is profitable (12.02% net margin) while DRTS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricDRTSETON
P/E ratioN/A144.62
Forward P/EN/A51.14
P/S ratioN/A14.43
P/B ratio30.5332.71
EV / EBITDAN/A73.17
FCF yieldN/A0.97%

Profitability

MetricDRTSETON
Gross margin0.00%57.87%
Operating margin0.00%0.09%
Net margin0.00%12.02%
ROE-210.13%27.24%
ROIC-40.47%20.41%

Growth (annualized)

MetricDRTSETON
Revenue CAGR (5Y)N/A47.98%
Total return CAGR (5Y)8.59%63.04%

Frequently asked

Is DRTS or ETON more profitable?
ETON runs the higher net margin — DRTS at 0.00% versus ETON at 12.02%.
How have DRTS and ETON total returns compared?
Over the past 5 years, DRTS delivered 8.59% and ETON delivered 63.04% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.